Welcome to LookChem.com Sign In|Join Free
  • or
5-Benzyloxy-2-Methoxybenzoesaeure-Methylester is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

52329-04-1

Post Buying Request

52329-04-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

52329-04-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 52329-04-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,2,3,2 and 9 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 52329-04:
(7*5)+(6*2)+(5*3)+(4*2)+(3*9)+(2*0)+(1*4)=101
101 % 10 = 1
So 52329-04-1 is a valid CAS Registry Number.

52329-04-1Relevant academic research and scientific papers

POLYCYCLIC AMIDES AS UBE2K MODULATORS FOR TREATING CANCER

-

Paragraph 00189; 00192-00193, (2021/07/10)

Provided are compounds of Formula (I) and pharmaceutically acceptable salts and compositions thereof, which are useful for treating conditions associated with modulation of UBE2K.

BIARYL-PROPIONIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS

-

Page/Page column 48, (2014/10/15)

The present invention relates to compounds of the formula (I), wherein X, R, R1, R2, D, E1, E2, E3, E4, G1, G2, G3 and G4 have the meanings indicated in the claims, which are valuable pharmaceutical active compounds. They are inhibitors of the protease ca

Biaryl-propionic acid derivatives and their use as pharmaceuticals

-

Paragraph 0130; 0131, (2014/10/16)

The present invention relates to compounds of the formula I, wherein X, R, R1, R2, D, E1, E2, E3, E4, G1, G2, G3 and G4 have the meanings indicated in the claims, which are valuable pharmaceutical active compounds. They are inhibitors of the protease cath

BIARYL-PROPIONIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS

-

Page/Page column 48, (2014/10/15)

The present invention relates to compounds of the formula (I), wherein X, R, R1, R2, D, E1, E2, E3, E4, G1, G2, G3 and G4 have the meanings indicated in the claims, which are valuable pharmaceutical active compounds. They are inhibitors of the protease ca

Biaryl-Propionic Acid Derivatives and their Use as Pharmaceuticals

-

Paragraph 0140; 0141, (2014/10/16)

The present invention relates to compounds of the formula I, wherein X, R, R1, R2, D, E1, E2, E3, E4, G1, G2, G3 and G4 have the meanings indicated in the claims, which are valuable pharmaceutical active compounds. They are inhibitors of the protease cath

IMIDAZOPYRIDINE COMPOUNDS

-

Page/Page column 23, (2010/04/23)

Compounds, pharmaceutical compositions, kits and methods are provided for use with glucokinase that comprise a compound selected from the group consisting of formula (I) wherein the variables are as defined herein.

SYNTHESIS OF PEPTIDE ALKALOIDS-III. AMINO ACIDS AND PEPTIDES-XXXII. SYNTHESIS OF DIHYDRO-ZIZYPHINE A AND B

Schmidt, Ulrich,Boekens, Hilmar,Lieberknecht, Albrecht,Griesser, Helmut

, p. 4949 - 4952 (2007/10/02)

Recently we described a new cyclisation method for the synthesis of ansa peptides by hydrogenolysis of Z-pentafluorophenyl ester and ring closure on the surface of the palladium catalyst.We applied this reaction to the synthesis of the 14-membered ansa pe

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 52329-04-1